Earlier Report Observations
The market for retail insulin medicaments in Hungary declined from $1.7 million in production and a market size of $135.3 million in 2018 to $125.7 million in 2019. By 2022, the market had contracted sharply to $60.4 million. This drop coincided with the withdrawal of four insulin preparations by Sanofi from the Hungarian market, disrupting supply for thousands of patients, alongside regulatory tightening that introduced stricter prescribing and dispensing rules as well as modified licensing and packaging requirements for controlled substances like insulin.
A slight recovery to $62.5 million occurred in 2023, supported by the launch of a new combination drug, Suliqua, which expanded treatment options. The market continued to grow in 2024, reaching $68.1 million, while export values remained elevated above $110 million throughout the period.
Table of content
- 1. Disclaimer
- 2. Terms of use of the report
- 3. Product codes in the statistical classifications used in the report
-
4. Key Market Indicators
-
4.1. In value
- 4.1.1. Production, 2018-2019, 2022-2024
- 4.1.2. Imports, 2018-2025
- 4.1.3. Exports, 2018-2025
- 4.1.4. Market size, 2018-2019, 2022-2024
-
4.1. In value
-
5. Production
-
5.1. Production in Hungary
- 5.1.1. In value, 2018-2019, 2022-2024, K $ US
-
5.2. Production in the EU, 2018-2024
- 5.2.1. In value, 2018-2024, K $ US
-
5.1. Production in Hungary
-
6. Exports
-
6.1. Exports (Direct Data)
- 6.1.1. Exports - Total information
-
6.1.2. Exports in kind, t
- 6.1.2.1. Annual dynamics of product's exports from Hungary in kind, 2018-2025, t
- 6.1.2.2. Dynamics of product's exports in kind from Hungary by countries, 2018-2025, t
- 6.1.2.3. Structure of product's exports in kind by countries, 2018-2025
-
6.1.3. Exports in value, M $ US
- 6.1.3.1. Annual dynamics of product's exports from Hungary in value, 2018-2025, M $ US
- 6.1.3.2. Dynamics of product's exports in value from Hungary by countries, 2018-2025, M $ US
- 6.1.3.3. Structure of product's exports in value by countries, 2018-2025
-
6.1.4. Average price of product's exports, $ US/kg
- 6.1.4.1. Annual dynamics of average price of product's exports from Hungary, 2018-2025, $ US/kg
- 6.1.4.2. Dynamics of average price of product's exports from Hungary by countries, 2018-2025, $ US/kg
-
6.2. Exports (Mirror Data)
- 6.2.1. Exports - Total information
-
6.2.2. Exports in kind, t
- 6.2.2.1. Annual dynamics of product's exports from Hungary in kind, 2018-2025, t
- 6.2.2.2. Dynamics of product's exports in kind from Hungary by countries, 2018-2025, t
- 6.2.2.3. Structure of product's exports in kind by countries, 2018-2025
-
6.2.3. Exports in value, M $ US
- 6.2.3.1. Annual dynamics of product's exports from Hungary in value, 2018-2025, M $ US
- 6.2.3.2. Dynamics of product's exports in value from Hungary by countries, 2018-2025, M $ US
- 6.2.3.3. Structure of product's exports in value by countries, 2018-2025
-
6.2.4. Average price of product's exports, $ US/kg
- 6.2.4.1. Annual dynamics of average price of product's exports from Hungary, 2018-2025, $ US/kg
- 6.2.4.2. Dynamics of average price of product's exports from Hungary by countries, 2018-2025, $ US/kg
-
6.1. Exports (Direct Data)
-
7. Imports
-
7.1. Imports (Direct Data)
- 7.1.1. Imports - Total information
-
7.1.2. Imports in kind, t
- 7.1.2.1. Annual dynamics of product's imports to Hungary in kind, 2018-2025, t
- 7.1.2.2. Dynamics of product's imports in kind to Hungary by countries, 2018-2025, t
- 7.1.2.3. Structure of product's imports in kind by countries, 2018-2025
-
7.1.3. Imports in value, M $ US
- 7.1.3.1. Annual dynamics of product's imports to Hungary in value, 2018-2025, M $ US
- 7.1.3.2. Dynamics of product's imports in value to Hungary by countries, 2018-2025, M $ US
- 7.1.3.3. Structure of product's imports in value by countries, 2018-2025
-
7.1.4. Average price of product's imports, $ US/kg
- 7.1.4.1. Annual dynamics of average price of product's imports to Hungary, 2018-2025, $ US/kg
- 7.1.4.2. Dynamics of average price of product's imports to Hungary by countries, 2018-2025, $ US/kg
-
7.2. Imports (Mirror Data)
- 7.2.1. Imports - Total information
-
7.2.2. Imports in kind, t
- 7.2.2.1. Annual dynamics of product's imports to Hungary in kind, 2018-2025, t
- 7.2.2.2. Dynamics of product's imports in kind to Hungary by countries, 2018-2025, t
- 7.2.2.3. Structure of product's imports in kind by countries, 2018-2025
-
7.2.3. Imports in value, M $ US
- 7.2.3.1. Annual dynamics of product's imports to Hungary in value, 2018-2025, M $ US
- 7.2.3.2. Dynamics of product's imports in value to Hungary by countries, 2018-2025, M $ US
- 7.2.3.3. Structure of product's imports in value by countries, 2018-2025
-
7.2.4. Average price of product's imports, $ US/kg
- 7.2.4.1. Annual dynamics of average price of product's imports to Hungary, 2018-2025, $ US/kg
- 7.2.4.2. Dynamics of average price of product's imports to Hungary by countries, 2018-2025, $ US/kg
-
7.1. Imports (Direct Data)
-
8. Trade balance
-
8.1. Trade balance (Direct Data)
- 8.1.1. In kind, t
- 8.1.2. In value, M $ US
-
8.2. Trade balance (Mirror Data)
- 8.2.1. In kind, t
- 8.2.2. In value, M $ US
-
8.1. Trade balance (Direct Data)
-
9. Top buying and selling countries, 2018-2025
-
9.1. Direct Data
- 9.1.1. Import in Value by Countries-buyers
- 9.1.2. Export in Value by Countries-suppliers
-
9.2. Mirror Data
- 9.2.1. Import in Value by Countries-buyers
- 9.2.2. Export in Value by Countries-suppliers
-
9.1. Direct Data
Production for retail sale medicaments with insulin in Hungary
In value, 2018-2021, K $ US
In 2019, Hungary's output of retail sale medicaments with insulin was valued at 1 654 K $ US, marking a slight decline of 2.7% compared to the previous year.
Annual dynamics of production in Hungary in value, 2018-2021, K $ US
| Parameter | 2019 | 2020 | 2021 | CAGR | |
|---|---|---|---|---|---|
| 1 | Change from last year | (2.7%) | n/a | n/a | - |
Exports for retail sale medicaments with insulin from Hungary
Exports in kind, t
Hungary's exports of retail sale medicaments with insulin increased for the third consecutive year. In 2021, exports amounted to 577.9 t, reflecting a rise of 26.6% compared to 2020. Over the period from 2018 to 2021, exports grew by 43%, with a compound annual growth rate (CAGR) of 12.7%.
Annual dynamics of product's exports from Hungary in kind, 2018-2021, t
| Parameter | 2019 | 2020 | 2021 | CAGR | |
|---|---|---|---|---|---|
| 1 | Change from last year | 3.1% | 9.5% | 26.6% | 12.7% |
From 2018 to 2021, Romania, Lithuania, and Bulgaria were the primary buyers of retail sale medicaments with insulin from Hungary in terms of volume. Romania accounted for 55.6% of exports in kind, Lithuania for 9.3%, and Bulgaria for 7.2%, collectively representing 72.0% of total exports in kind.
Structure of product's exports in kind by countries, 2018-2021
World map of product's exports from Hungary in kind, 2018-2021
Exports in value, M $ US
Shipments of retail sale medicaments with insulin from Hungary to abroad increased for the third consecutive year. In 2021, exports reached 112.7 M $ US, showing a dramatic increase of 40.8% versus the previous year. Over the period from 2018 to 2021, exports rose by 54.2%, with a compound annual growth rate (CAGR) of 15.5%.
Annual dynamics of product's exports from Hungary in value, 2018-2021, M $ US
| Parameter | 2019 | 2020 | 2021 | CAGR | |
|---|---|---|---|---|---|
| 1 | Change from last year | 3.9% | 5.4% | 40.8% | 15.5% |
Between 2018 and 2021, Romania, Lithuania, and Croatia led the structure of exports in value terms. Romania accounted for 50.0% of exports in value, Lithuania for 10.4%, and Croatia for 8.3%, together representing 68.7% of total flows.
Structure of product's exports in value by countries, 2018-2021
World map of product's exports from Hungary in value, 2018-2021
Imports for retail sale medicaments with insulin to Hungary
Imports in kind, t
After a two-year rise, foreign supplies of retail sale medicaments with insulin to Hungary declined. In 2021, imports amounted to 855.0 t, down by 12.1% over the past year. Between 2018 and 2021, imports increased by 3.8%, equating to an annualized rate of 1.3%. The maximum value was recorded in 2020 at 972.3 t, following the largest increase of 10.6% in 2019.
Annual dynamics of product's imports to Hungary in kind, 2018-2021, t
| Parameter | 2019 | 2020 | 2021 | CAGR | |
|---|---|---|---|---|---|
| 1 | Change from last year | 10.6% | 6.8% | (12.1%) | 1.3% |
From 2018 to 2021, France was the dominant destination for imports in kind of retail sale medicaments with insulin to Hungary, accounting for 71.2% of total flows, while the remaining share was distributed among a number of smaller markets.
Structure of product's imports in kind by countries, 2018-2021
World map of product's imports to Hungary in kind, 2018-2021
Imports in value, M $ US
In 2021, Hungary's imports of retail sale medicaments with insulin totalled 182.8 M $ US, constituting a robust decline of 11.7% year-over-year. Over the period from 2018 to 2021, imports decreased by 11.6%, with a compound annual growth rate (CAGR) of -4.0%. The maximum value was recorded in 2020 at 207.0 M $ US, which saw the largest increase of 3.5% that year.
Annual dynamics of product's imports to Hungary in value, 2018-2021, M $ US
| Parameter | 2019 | 2020 | 2021 | CAGR | |
|---|---|---|---|---|---|
| 1 | Change from last year | (3.2%) | 3.5% | (11.7%) | (4.0%) |
Between 2018 and 2021, France and Denmark dominated imports in value terms, accounting together for 85.4% of total flows, with other destinations having smaller individual contributions.
Structure of product's imports in value by countries, 2018-2021
World map of product's imports to Hungary in value, 2018-2021
Related Reports
Blood-grouping reagents market in Hungary
2026-03-29
Shaving preparations market in Hungary
2026-03-29
Why Choose Us?
Only Verified Data
No Hidden Costs or Separate Fees
Smarter Subscription Pricing
Contact Our Team
Submit your inquiry using the form below — our team will get back to you within 24 hours.